More on Amiodarone-Meeting the Challenges of the Combined Epidemics of Heart Failure and Atrial Fibrillation?

Abstract

References

1. Charlier R , Deltour G , Baudine B , et al. Pharmacology of amiodarone, an antianginal drug with a new biological profile. Artzneim Forsch 18:1408-1417, 1968

2. Singh BN , Vaughan Williams EM . The effect of amiodarone, a new antianginal drug, on cardiac muscle. Br J Pharmacol 39:657-667, 1970

3. Singh BN . Amiodarone: Historical development and pharmacologic profile. Am Heart J 106:788-793, 1983

4. Singh BN . Amiodarone: The expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol 20:608-618, 1997

5. Hauswirth O , Singh BN . Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev 30:5-63, 1979

6. Singh BN , Zipes DP . Amiodarone: Basic concepts and clinical applications. Am Heart J 106(4):787-964, 1983

7. Chun SH , Sager PT , Stevenson WG , et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 76:47-50, 1995

8. Kudenchuk PJ , Cobb L , Copass M , et al. Amiodarone for resuscitaion after out of hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341:871-878, 1999

9. Dorian P , Cass D , Schwartz B , et al. Amiodarone as compared with lidocaine for shock resistant ventricular fibrillation. N Engl J Med 346:884-890, 2002

10.

10. Roy D , Talajic M , Dorian P , et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-920, 2000.

11.

11. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: An international consensus on science . Advanced cardiovascular life support. 5. Pharmacology 1: Agents for arrhythmias. Circulation 102(Suppl):112-128, 2000

12.

12. Nademanee K , Taylor R , Bailey W , et al. Treating electrical storm: Sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102(7):742-747, 2000

13.

13. Srivatsa U , Ebrahimi R , El-Bialy A , et al. Electrical storm: Case series and review of management. J Cardiovasc Pharmacol Therapeut, 8:237-246, 2003

14.

14. Amiodarone Trials Meta-Analysis Investigators . Effect of prophylactic amidoarone on mortality after myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomized trials. Lancet 350:1417-1424, 1997

15.

15. Antimisiaris M , Sarma JS , Schoenbaum MP , et al. Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: Significance for the control of sudden cardiac death. Am Heart J 128(5):884-891, 1994

16.

16. Boutitie F , Boissel JP , Connolly SJ , et al. Amiodarone interaction with beta-blockers: Analysis of the merged EMIAT and CAMIAT databases. Circulation 99:2268-2275, 1999

17.

17. Choo DC , Huiskes B , Jones J , et al. Amiodarone rescue therapy for severe decompensated heart failure initially unsuitable for beta-blockers. J Cardiovasc Pharmacol Therapeut (this volume) 2003

18.

18. Galperin J , Elizari MV , Chiale PA , et al for the GEFACA Investigators. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance. J Cardiovasc Pharmacol Therapeut 8:179-186, 2003

19.

19. Nul DR , Doval HC , Grancelli HO , et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insufficiencia Cardiaca en Argentina-Grupo de Estudios Multicentricos en Argentina. JAm Coll Cardiol 29:1199-1205, 1997

20.

20. Hamer AWF , Arkles LB , Johns JA . Beneficial effects of low dose amiodarone in patients with heart failure: Placebo-controlled trial. Am J Cardiol 14:1768-1773, 1989

21.

21. Singh SN , Fletcher RD , Fisher SG , et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. N Engl J Med 333:77-82, 1995

22.

22. Deedwania PC , Singh BN , Ellenbogan K , et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 25:2574-2579, 1998

23.

23. Massie BM , Fisher SG , Dedwania PC , et al for the CHF STAT Investigators. Effect of amiodarone in clinical status and left ventricular function in patients with congestive heart failure. Circulation 93:2128-2134, 1996

24.

24. Braunwald E. Shattuck Lecture . Cardiovascular medicine at the tum of the millennium: Triumphs, concems and opportunities. N Engl J Med 337:1360-1369, 1997

25.

25. Scheinman MM . Atrial fibrillation and congestive heart failure: The intersection of two common diseases. Circulation 98:941-942, 1998